Compass Financial Management’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
Other funds holding NVS
Compass Financial Management's NVS Position: Q3 2026 in Review
Compass Financial Management increased its Novartis (NVS) stake by 2.4% in Q3 2026, buying an estimated $19.6K and bringing the position to 5,464 shares worth $779K. The position accounts for 0.08% of the portfolio, ranked #220.
Compass Financial Management first reported a position in NVS in Q2 2026 and has held it in 2 quarters since. The position peaked at $819K in Q2 2026. 1,543 funds tracked by Wall St. Rank hold NVS as of Q3 2026.
- Compass Financial Management held 5,464 shares of Novartis worth $779K as of Q3 2026.
- Compass Financial Management bought 129 Novartis shares in Q3 2026, an estimated $19.6K.
- Novartis made up 0.08% of Compass Financial Management's portfolio in Q3 2026, its #220 holding.
- Compass Financial Management first reported a position in Novartis in Q2 2026 and has held it in 2 quarters since.
- Compass Financial Management's Novartis position peaked at $819K in Q2 2026.
- 1,543 funds tracked by Wall St. Rank held Novartis as of Q3 2026.
Based on Compass Financial Management's 13F filing for Q3 2026, filed 30 Oct 2026.